Aerpio Pharmaceuticals, Inc. logo
Aerpio Pharmaceuticals, Inc. ARPO
$ 2.2 -0.9%

Aerpio Pharmaceuticals, Inc. Income Statement 2011-2024 | ARPO

Annual Income Statement Aerpio Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

63.6 M 26.4 M 132 M 108 M - - - - - -

Shares

42.1 M 40.6 M 33.9 M 21.7 M - - - - - -

Net Income

-4.32 M -23.3 M -10.4 M -21.4 M -39.4 K -31.4 K -28.7 K -27.4 K -27.2 K -22.4 K

Revenue

15 M - 20.2 M - - - - - - -

EBITDA

-6.22 M -22.4 M -11.1 M -21.3 M -29.5 K -23 K -22.8 K -22.4 K -23.6 K -20.5 K

Operating Expenses

21.3 M 22.4 M 31.3 M 21.4 M 29.5 K 23 K 22.8 K 22.4 K 23.6 K 20.5 K

General and Administrative Expenses

8.76 M 9.76 M 13.5 M 9.24 M 29.5 K 23 K 22.8 K 22.4 K 23.6 K 20.5 K

All numbers in USD currency